XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Note 14 - Research and Development Expenses
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Research, Development, and Computer Software Disclosure [Text Block]

NOTE 14: RESEARCH AND DEVELOPMENT EXPENSES 

 

  

Three months ended

September 30,

  

Nine months ended

September 30,

 
  

2024

  

2023

  

2024

  

2023

 

Salary and employee benefits

 $711  $317  $1,154  $571 

Consultants and subcontractors

  100   25   177   48 

Depreciation

  4   -   8   - 

Clinical trials

  -   -   -   19 

Expenses - other

  63   50   178   74 

Total

 $878  $392  $1,517  $712